Buy Torrent Pharmaceuticals, target Rs 1,600: Kunal Bothra
Buy Torrent Pharmaceuticals Ltd. at a price target of Rs 1600.0 and a stoploss at Rs 1520 from entry point.

Torrent Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 5556.72 Crore to Sales Value (96.42 % of Total Sales), Other Operating Revenue which contributed Rs 129.59 Crore to Sales Value (2.24 % of Total Sales) and Export Incentives which contributed Rs 76.17 Crore to Sales Value (1.32 % of Total Sales)for the year ending 31-Mar-2019.
For the quarter ended 31-03-2019, the company has reported a Consolidated sales of Rs 1822.00 Crore, down -6.47 % from last quarter Sales of Rs 1948.00 Crore and up 8.45 % from last year same quarter Sales of Rs 1680.00 Crore Company has reported net profit after tax of Rs -152.00 Crore in latest quarter. The company’s top management includes Dr.Chaitanya Dutt, Mr.Haigreve Khaitan, Mr.Samir Mehta, Mr.Shailesh Haribhakti, Mr.Sudhir Mehta, Ms.Ameera Shah, Ms.Nayantara Bali. Company has BSR & Co. LLP as its auditoRs As on 31-03-2019, the company has a total of 169,222,720 shares outstanding.
Download ET Markets APP